According to an April 15 survey by healthcare company Tebra, more than a third of users of glucagon-like peptide-1 (GLP-1) receptor agonists are currently microdosing Ozempic and similar prescriptions, primarily due to the potential side effects associated with the drugs
It minimizes the risk of major cardiovascular events, including heart attack and stroke, by improving weight, blood sugar, and lipid profiles
While this has improved accessibility for chronic diabetic patients, it has simultaneously enabled the "off-label" use for weight loss among the general public
J Mol Neurosci 71:215224 Kwon JY, Jung UJ, Kim DW, Kim S, Moon GJ, Hong J, Jeon MT, Shin M, Chang JH, Kim SR (2018) Beneficial effects of hesperetin in a mouse model of temporal lobe epilepsy